Dermatology · Fontana, CA
NPI
1023189081
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9961 Sierra Ave
Fontana, CA, 92335
Phone (909) 427-3910
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,020
20 services
Medicare patients, 2024
19
Average age 66
Drug cost, 2024
$246K
1,351 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Monika U Curlin prescribed most often to Medicare patients was Fluocinonide, with 130 prescriptions and refills. In total Monika U Curlin wrote 1,351 Medicare prescriptions that cost $246K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Fluocinonide Generic | 130 | 136 | 62 | $2,366 |
| Ketoconazole Generic | 113 | 124 | 63 | $2,248 |
| Retin-A Tretinoin | 107 | 107 | 46 | $2,900 |
| Triamcinolone Acetonide Generic | 104 | 128 | 75 | $1,772 |
| Metronidazole Generic | 101 | 105 | 51 | $1,575 |
| Clobetasol Propionate Generic | 89 | 93 | 41 | $2,325 |
| Hydrocortisone Generic | 77 | 84 | 55 | $1,284 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 72 | 76 | 34 | $2,636 |
| Fluorouracil Generic | 67 | 71 | 49 | $2,813 |
| Clindamycin Phosphate Generic | 48 | 48 | 24 | $1,116 |
| Hydroxyzine Hcl Generic | 40 | 55 | 16 | $1,669 |
| Tacrolimus Generic | 39 | 40 | 17 | $2,883 |
| Doxycycline Monohydrate Generic | 37 | 73 | 24 | $1,568 |
| Mupirocin Generic | 25 | 25 | 17 | $244 |
| Mometasone Furoate Generic | 23 | 23 | 13 | $795 |
Brand drugs: 177 claims; generic drugs: 1,174 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Monika U Curlin were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.